PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 11286313-6 2001 Similar results were demonstrated in the National Investigators Collaborating on Enoxaparin (NICE-4) study using a combination of abciximab and enoxaparin in patients undergoing PCI. Enoxaparin 81-91 ubiquitin associated protein 2 like Homo sapiens 93-99 12730628-2 2003 NICE-4, a recent PCI observational study, evaluated a reduced dose of intravenous (IV) enoxaparin (0.75 mg/kg) with abciximab. Enoxaparin 87-97 ubiquitin associated protein 2 like Homo sapiens 0-6 11286313-6 2001 Similar results were demonstrated in the National Investigators Collaborating on Enoxaparin (NICE-4) study using a combination of abciximab and enoxaparin in patients undergoing PCI. Enoxaparin 144-154 ubiquitin associated protein 2 like Homo sapiens 93-99 10731289-4 2000 The preliminary experience with combining abciximab and intravenous enoxaparin during percutaneous coronary intervention in the NICE-4 Trial demonstrates a low incidence of minor/major bleeding (TIMI definition) and transfusion and infrequent major cardiac events to 30 days follow-up. Enoxaparin 68-78 ubiquitin associated protein 2 like Homo sapiens 128-134